Armstrong Advisory Group’s Medifast MED Stock Holding History

Armstrong Advisory Group’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-83	Closed	-$1.46K	–	960
2025 Q1	$1.46K	Hold	83	–	–	﹤0.01%	797
2024 Q4	$1.46K	Hold	83	–	–	﹤0.01%	797
2024 Q3	$1.59K	Hold	83	–	–	﹤0.01%	739
2024 Q2	$1.81K	Hold	83	–	–	﹤0.01%	739
2024 Q1	$5.58K	Hold	83	–	–	﹤0.01%	631
2023 Q4	$5.58K	Sell	83 -29	-26%	-$2.02K	﹤0.01%	631
2023 Q3	$8.38K	Buy	112 +29	+35%	+$2.57K	﹤0.01%	631
2023 Q2	$7.65K	Hold	83	–	–	﹤0.01%	619
2023 Q1	$8.61K	Hold	83	–	–	﹤0.01%	588
2022 Q4	$9.57K	Buy	+83	New	+$9.66K	﹤0.01%	592

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Armstrong Advisory Group's MED Position: Q2 2025 in Review

Armstrong Advisory Group sold out of Medifast (MED) in Q2 2025, closing a stake of 83 shares — an estimated $1.46K sold.

Armstrong Advisory Group first reported a position in MED in Q4 2022 and held it in 10 quarters. The position peaked at $9.57K in Q4 2022. 120 funds tracked by Wall St. Rank hold MED as of Q2 2025.

Armstrong Advisory Group reported no remaining Medifast position as of Q2 2025 after selling out during the quarter.
Armstrong Advisory Group sold 83 Medifast shares in Q2 2025, an estimated $1.46K.
Armstrong Advisory Group first reported a position in Medifast in Q4 2022 and held it in 10 quarters.
Armstrong Advisory Group's Medifast position peaked at $9.57K in Q4 2022.
120 funds tracked by Wall St. Rank held Medifast as of Q2 2025.

Based on Armstrong Advisory Group's 13F filing for Q2 2025, filed 14 Jul 2025.